advertisement
ACT

June 9/2020

news roundup

ERT Survey of Virtual Trial Technologies Released

During the COVID-19 lockdown, in April and May 2020, ERT surveyed clinical professionals on how the demands of the pandemic were affecting their organizations’ use and planned use of virtual trial technologies.


Almac Group Announces Awards for COVID-19 Studies

Almac Group has received a $288,000 grant to support a clinical study in Sub-Saharan Africa in efforts to find a treatment for Coronavirus.


Greenphire Launches Budgeting Solution

Greenphire launched EnvisiX, which integrates with eClinicalGPS, Greenphire’s site payment solution, to further financial oversight from budget creation and negotiation to management, execution, and tracking of global investigator grants.

In this edition

Emerging Practices Employing CDISC Standards in Clinical Trials
Almac Group Announces Awards for COVID-19 Studies


Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »

Events

DIA 2020 Global Annual Meeting, Now Virtual
Search Upcoming Events
advertisement

Laboratory Solutions to Support Global COVID-19 Clinical Trials
Thursday, June 11, 2020 at 11am EDT
Learn more

Articles

Initial Design Considerations for Immuno-oncology Trials

The authors offer insights insights gained through interactions with regulatory authorities in the European and U.S. market, which are corroborated by reviewing current and relevant guidance and literature in immuno-oncology drug development.


Emerging Practices Employing CDISC Standards in Clinical Trials

Most companies are using CDISC standards in ongoing trials and are transforming legacy data to a compliant format. However, these same companies should consider the standards much earlier in the typical trial planning and design process to fully exploit their use.


advertisement

Clinical Trials: Navigating Disruption to Thriving
Wednesday, June 17, 2020 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST
Read the article

Blog Posts

Immuno-Oncology Enterprises Entering COVID

Lori McDermott, VP, Clinical Development & Regulatory Affairs at immuno-oncology biopharma Heat Biologics, discusses the company’s approach towards developing a COVID therapy

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
LHenderson@mjhlifesciences.com

Advertise

Todd Baker
Group Publisher
TBaker@mjhlifesciences.com